To examine clinical outcomes in patients undergoing treatment for achalasia or esophageal motility disorders (EMDs) in conjunction with bariatric surgery, with a specific focus on the sequencing of treatments to optimize outcomes.
Key Findings:
Patients with achalasia and obesity present diagnostic and therapeutic challenges due to overlapping symptoms and require tailored management strategies.
Achalasia was identified in up to 1% of individuals with severe obesity, indicating a significant intersection of these conditions.
Bariatric surgery may unmask or exacerbate EMDs, contributing to post-obesity esophageal dysfunction in up to 40% of cases, necessitating careful preoperative evaluation.
Interpretation:
The coexistence of achalasia and obesity complicates management, necessitating careful consideration of treatment sequencing to optimize clinical outcomes.
Limitations:
Descriptive nature limits generalizability.
No sample size calculations performed due to rarity of cases.
Potential for incomplete data affecting diagnosis and outcomes.
Retrospective design may introduce biases in data collection and interpretation.
Conclusion:
Findings suggest a need for a tailored approach in managing patients with achalasia and obesity undergoing bariatric surgery, highlighting the complexity of their care and the importance of treatment sequencing.
by Pattharasai Kachornvitaya, Melissa V. Wills, Baraa K. Mohamed, Valentin Mocanu, Juan S. Barajas-Gamboa, Xinlei Zhu, Yung Lee, Ricard Corcelles, Andrew T. Strong, Suthep Udomsawaengsup, Salvador Navarrete, Jerry Dang, Matthew Kroh
